队列内试验设计在肿瘤学中提升入组效率与结果外推性
该研究在两个放疗中心开展首个肿瘤放疗领域的队列内试验(TwiCs),将直肠癌患者纳入前瞻性队列并提供广泛知情同意后随机。200例合格患者中128例(64%)被随机,干预组64例中52例(81%)接受干预。试验患者与荷兰国家癌症登记人群在年龄、合并症和疾病分期上可比。
要点
- TwiCs设计在肿瘤临床中可行,可随机化高比例合格患者
- 干预接受率81%,试验期间曾暂时下降并据此调整样本量
- 试验患者与全国登记人群特征可比,支持结果外推
核心结论
- TwiCs设计在肿瘤临床环境中可行,能提高随机化患者比例并有利于试验效率与结果外推性。
研究设计与样本
- 在两家放疗中心开展前瞻性队列研究,患者提供广泛知情同意后直接随机。
- 200例合格直肠癌患者中128例(64%)被随机,干预组64例中52例(81%)接受干预。
主要发现
- 200例合格患者中128例(64%)被随机。
- 干预组64例中52例(81%)接受干预。
- 试验期间接受率曾暂时下降,随后调整了样本量。
- 试验患者在年龄、合并症和疾病分期上与荷兰国家直肠癌人群可比。
临床怎么用
- 在肿瘤临床研究中可采用TwiCs设计以提高入组效率并增强结果外推性。
- 需关注干预接受率变化对样本量的影响并及时调整。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The trials within cohorts (TwiCs) design aims to improve recruitment efficiency. We conducted the first TwiCs in radiation oncology and described efficiency of the design and generalizability of the results. STUDY DESIGN AND SETTING: In two radiotherapy centers, patients with rectal cancer were asked to participate in a prospective cohort study and to provide broad consent for randomization and patient-reported outcomes (PROs). Consenting patients who met the trial criteria were randomized directly after cohort enrollment. The intervention arm was offered a radiotherapy boost. We evaluated acceptance rate, its impact on sample size, and compared clinical characteristics between trial participants and patients of the Dutch national cancer registry. RESULTS: 128 of the 200 eligible patients (64%) were randomized. Sixty-two patients did not consent (in time) to cohort participation, to broad randomization, or to PROs. Of the 64 patients in the intervention arm, 52 (81%) accepted the intervention. During the trial, the acceptance rate dropped temporarily, after which sample size was adapted. Trial patients were comparable in age, comorbidity, and disease stage to the national rectal cancer population. CONCLUSIONS: The TwiCs design is feasible, allows enrollment of a high proportion of randomizable patients, with positive impact on trial efficiency and generalizability of results in a clinical oncology setting.
引用
- Couwenberg AM, Burbach JPM, May AM, et al. The trials within cohorts design facilitated efficient patient enrollment and generalizability in oncology setting. J Clin Epidemiol. 2019. PMID: 31866471. doi:10.1016/j.jclinepi.2019.12.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。